Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of the National Diabetes and Digestive and Kidney Diseases Advisory Council.
The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the provisions set forth in section 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council.
Date: February 2-3, 2000.
Open: February 2, 2000, 8:30 a.m. to 12 p.m.
Agenda: Grant applications.
Place: National Institutes of Health, Building 31, Conference Room 10, Bethesda, MD 20892.
Closed: February 3, 2000, 8:30 a.m. to 9 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, Conference Room 10, Bethesda, MD 20892.
Open: February 3, 2000, 9 a.m. to 12 p.m.
Agenda: Grant applications.
Place: National Institutes of Health, Building 31, Conference Room 10, Bethesda, MD 20892.
Contact Person: Walter S. Stolz, PhD., Director for Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, PHS, DHHS, Bethesda, MD 20892.
Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council Kidney, Urologic and Hematologic Diseases Subcommittee..
Date: February 2, 2000.
Open: 1:30 p.m. to 2:30 p.m.
Agenda: Grant applications.
Place: National Institutes of Health, 9000 Rockville Pike, Building 31, Conference Room 7.
Closed: 2:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 9000 Rockville Pike, Building 31, Conference Room 7.
Contact Person: Walter S. Stolz, PhD., Director for Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, PHS, DHHS, Bethesda, MD 20892.
Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council Diabetes, Endocrine and Metabolic Diseases Subcommittee.
Date: February 2, 2000.
Open: 1:30 p.m. to 2:30 p.m.
Agenda: Grant applications.
Place: National Institutes of Health, Building 31, Conference Room 10, Bethesda, MD 20892.
Closed: 2:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, Conference Room 10, Bethesda, MD 20892.
Contact Person: Walter S. Stolz, PhD., Director for Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, PHS, DHHS, Bethesda, MD 20892.
Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council Digestive Diseases and Nutrition Subcommittee.
Date: February 2, 2000.
Open: 1:30 p.m. to 2:30 p.m.
Agenda: Grant applications.
Place: National Institutes of Health, 9000 Rockville Pike, Building 31, Conference Room 9A51.
Closed: 2:30 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 9000 Rockville Pike, Building 31, Conference 9A51.
Contact Person: Walter S. Stolz, PhD., Director for Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, PHS, DHHS, Bethesda, MD 20892.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS).
Dated: January 11, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-1141 Filed 1-18-00; 8:45 am]
BILLING CODE 4140-01-M